Emerging Approaches for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease: The Application of Nanomedicines

作者
Te Shi,Haiyan Yue,Wen Wang,Yu Gao,Sheng Xu,Jie Gao,Chuan Yin
出处
期刊:International Journal of Nanomedicine [Dove Medical Press]
卷期号:Volume 21: 1-27 被引量:1
标识
DOI:10.2147/ijn.s603396
摘要

Abstract: Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 25% of the global population, with limited pharmacological treatment options. While lifestyle modification remains foundational, nanomedicine offers promising strategies to overcome drug delivery challenges, including poor solubility, low bioavailability, and off-target effects. This review systematically examines nanomedicine design strategies across four therapeutic domains: (1) lipid metabolism regulation, (2) anti-inflammatory and antioxidant therapy, (3) insulin sensitization, and (4) gene regulation. We critically analyze hepatic cell-specific targeting approaches, evaluate the biological effects of nanomedicines beyond drug delivery, and discuss the strengths and limitations of current preclinical evidence. Key challenges for clinical translation are examined, including long-term biosafety, animal model relevance, and the gap between preclinical promise and clinical reality. While recent FDA approvals of semaglutide and resmetirom for MASH with fibrosis represent significant progress, nanomedicine may address unmet needs through combination therapies, cell-specific targeting, and theranostic approaches. By integrating emerging trends in intelligent nanomedicine design, this review provides a roadmap for advancing nanomedicines from bench to bedside for MASLD treatment. The infographic illustrates the progression of liver conditions from MASH to cirrhosis and HCC, highlighting the role of nanomedicines in delaying MASLD. The top section shows the progression from MASH to cirrhosis and HCC. The central part emphasizes delaying MASLD progression with nanomedicines. The left section lists nanomedicine types: liposome, nanoemulsions, metal nanoparticle, micelle, carbon nanotube, vesicle and polymeric nanoparticle. The right section shows mechanisms: entrapment, adsorption and bonding. The bottom section presents drug types: hypolipidemic drugs, anti-inflammatory and antioxidant drugs, drugs to improve insulin resistance and gene therapy drugs.Infographic on MASLD progression, nanomedicines and drug types to delay disease. Keywords: metabolic dysfunction-associated steatotic liver disease, nanomedicines, drug delivery, targeted therapy

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
wanci的应助被爽朗的小王同学采纳,获得10
1秒前
瓶子完成签到 ,获得积分10
1秒前
甜美无剑发布了新的文献求助10
1秒前
李健的小迷弟的应助被youyyuy采纳,获得10
2秒前
3秒前
彳亍完成签到,获得积分10
3秒前
4秒前
斯文败类的应助被王新涛采纳,获得10
4秒前
4秒前
2339822272发布了新的文献求助10
4秒前
我是谁的应助被小胖采纳,获得30
5秒前
充电宝的应助被云晓采纳,获得10
6秒前
充电宝的应助被阿楠采纳,获得10
6秒前
yyt完成签到 ,获得积分10
6秒前
爆米花的应助被dan1029采纳,获得10
6秒前
Hello的应助被dan1029采纳,获得10
6秒前
李爱国的应助被dan1029采纳,获得10
6秒前
CodeCraft的应助被dan1029采纳,获得10
6秒前
6秒前
小蘑菇的应助被dan1029采纳,获得10
6秒前
6秒前
万能图书馆的应助被dan1029采纳,获得10
6秒前
Akim的应助被dan1029采纳,获得10
7秒前
sss完成签到 ,获得积分10
7秒前
李健的应助被dan1029采纳,获得10
7秒前
斯文雁易完成签到,获得积分10
7秒前
爆米花的应助被dan1029采纳,获得10
7秒前
04d的应助被dan1029采纳,获得10
7秒前
7秒前
啊吼吼完成签到,获得积分10
7秒前
7秒前
专注的半雪完成签到,获得积分10
7秒前
烟花的应助被CWJ采纳,获得10
7秒前
7秒前
黑米完成签到,获得积分10
7秒前
7秒前
Akim的应助被Crush采纳,获得10
8秒前
04d的应助被心碎的小蛋挞采纳,获得10
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180713
求助须知:如何正确求助?哪些是违规求助? 9570752
关于积分的说明 21814119
捐赠科研通 7776960
什么是DOI,文献DOI怎么找? 3433298
关于科研通互助平台的介绍 2557579
邀请新用户注册赠送积分活动 2479287